Can-Fite BioPharma Ltd. Revenue, Remaining Performance Obligation, Percentage
Can-Fite BioPharma Ltd. (CANF) had Revenue, Remaining Performance Obligation, Percentage of 22.00% as of 2025-06-30, per its 6-K filed 2025-08-28.
Financial Statements › Notes › Revenue, Performance Obligation
us-gaap:RevenueRemainingPerformanceObligationPercentage · last filed 2026-03-26
- 2025-06-30: Revenue, Remaining Performance Obligation, Percentage 22.00%.
- 2015-03-31: Revenue, Remaining Performance Obligation, Percentage 16.50%.
| Period end | Revenue, Remaining Performance Obligation, Percentage |
|---|---|
| 2025-06-30 | 22.00% 6-K · filed 2025-08-28 |
| 2015-03-31 | 16.50% 20-F · filed 2026-03-26 |